Zobrazeno 1 - 10
of 14
pro vyhledávání: '"M. Jose Serrano"'
Autor:
Antonio J. Ruiz-Rodríguez, Maria P. Molina-Vallejo, Inés Aznar-Peralta, Cristina González Puga, Inés Cañas García, Encarna González, Jose A. Lorente, M. Jose Serrano, M. Carmen Garrido-Navas
Publikováno v:
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Cancers
Cancers, Vol 13, Iss 6386, p 6386 (2021)
Cancers; Volume 13; Issue 24; Pages: 6386
instname
Cancers
Cancers, Vol 13, Iss 6386, p 6386 (2021)
Cancers; Volume 13; Issue 24; Pages: 6386
Ines Aznar-Peralta holds a "Garantia Juvenil" fellowship (contract number 8040), and M. Carmen Garrido-Navas has a postdoctoral fellowship funded by the Ministry of Economy, Competitiveness, Enterprises and Universities (DOC_01682).
The isolatio
The isolatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1abf532f0013cfa63291374fdb12ba4e
Autor:
M Carmen, Garrido-Navas, Abel, García-Díaz, Maria Pilar, Molina-Vallejo, Coral, González-Martínez, Miriam, Alcaide Lucena, Inés, Cañas-García, Clara, Bayarri, Juan Ramón, Delgado, Encarna, González, Jose Antonio, Lorente, M Jose, Serrano
Publikováno v:
Cancers
Simple Summary Most solid tumors share mutations in TP53 that is thus considered one of the main cancer driver genes. Mutations in TP53 occur very early during tumor development, so their identification helps in diagnosing cancer. Furthermore, knowin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::61d51f433a0525defdaa4d8f0709233d
https://pubmed.ncbi.nlm.nih.gov/33198130
https://pubmed.ncbi.nlm.nih.gov/33198130
The Polemic Diagnostic Role of TP53 Mutations in Liquid Biopsies from Breast, Colon and Lung Cancers
Autor:
Abel García-Díaz, José A. Lorente, M. Jose Serrano, Maria Pilar Molina-Vallejo, Clara Bayarri, Encarna González, Coral González-Martínez, Miriam Alcaide Lucena, Juan Ramón Delgado, M. Carmen Garrido-Navas, Inés Cañas-García
Publikováno v:
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Digibug: Repositorio Institucional de la Universidad de Granada
Universidad de Granada (UGR)
Cancers, Vol 12, Iss 3343, p 3343 (2020)
instname
Digibug: Repositorio Institucional de la Universidad de Granada
Universidad de Granada (UGR)
Cancers, Vol 12, Iss 3343, p 3343 (2020)
Simple Summary: Most solid tumors share mutations in TP53 that is thus considered one of the main cancer driver genes. Mutations in TP53 occur very early during tumor development, so their identification helps in diagnosing cancer. Furthermore, knowi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33f8d78823e2021dcd81f3d0791cfec4
Autor:
Alba Rodríguez-Martínez, M. Jose Serrano, Diego de Miguel-Pérez, Hugh Ilyine, Miguel Delgado-Ramirez, Jose Exposito-Hernandez, Francisco G. Ortega, Jose L. Garcia-Puche, Mayte Delgado-Ureña, M. Carmen Garrido-Navas, José A. Lorente
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-11 (2018)
Journal of Translational Medicine
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Journal of Translational Medicine
Digibug. Repositorio Institucional de la Universidad de Granada
instname
The use of circulating tumor cells (CTCs) as indicators of treatment response in metastatic colorectal cancer (mCRC) needs to be clarified. The objective of this study is to compare the Response Evaluation Criteria in Solid Tumors (RECIST) with the C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1068f76edd73589ece55465418056b57
http://link.springer.com/article/10.1186/s12967-018-1624-2
http://link.springer.com/article/10.1186/s12967-018-1624-2
Autor:
Lisa Hester, Christian Rolfo, Priyadarshini Mamindla, Mehmet E. Er, Diego de Miguel Perez, Sunjay Kaushal, Ru-ching Hsia, Francesco Buemi, Paolo Manca, Oscar Arrieta, Aung Naing, Rivka R. Colen, Murat Ak, Brandon Cooper, Christine B. Peterson, Vishal Peddagangireddy, M. Jose Serrano, Andrés F. Cardona, Muthukumar Gunasekaran, Alessandro Russo
Publikováno v:
Journal of Clinical Oncology. 39:e21144-e21144
e21144 Background: Immune-checkpoint inhibitors (ICIs) have revolutionized the therapeutic landscape of lung cancer patients. However, its low treatment efficacy is still an issue and the current standard of care tissue PD-L1 presents high variabilit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cc849ffc9261070559e41eae1e768b9
https://doi.org/10.1200/jco.2021.39.15_suppl.e21144
https://doi.org/10.1200/jco.2021.39.15_suppl.e21144
Autor:
Pedro Sánchez-Rovira, F. Gabriel. Ortega, Ana María Cameán Fernández, José A. Lorente, Josep M. Corominas, Marta Macià, J. Luis García-Puche, Miguel Delgado-Rodríguez, Rosa Nadal, Marta Salido, M. Jose Serrano, María Rodríguez-Rivera, Francesc Solé
Publikováno v:
International Journal of Cancer. 133:2398-2407
CD133 has been associated with cell properties such as self renewal, migration and vasculogenic mimicry, potentially involved in generation of circulating tumor cells (CTCs). We characterized CD133 expression in CTCs of 98 nometastatic breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08539045ebd781d2c92ba7a8d57e238c
https://doi.org/10.1002/ijc.28263
https://doi.org/10.1002/ijc.28263
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rosa, Nadal, F Gabriel, Ortega, Marta, Salido, Jose A, Lorente, Maria, Rodríguez-Rivera, Miguel, Delgado-Rodríguez, Marta, Macià, Ana, Fernández, Josep M, Corominas, J Luis, García-Puche, Pedro, Sánchez-Rovira, Francesc, Solé, M Jose, Serrano
Publikováno v:
International journal of cancer. 133(10)
CD133 has been associated with cell properties such as self renewal, migration and vasculogenic mimicry, potentially involved in generation of circulating tumor cells (CTCs). We characterized CD133 expression in CTCs of 98 nometastatic breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6fa5d706fcca5507501c67cc758f86ae
https://pubmed.ncbi.nlm.nih.gov/23661576
https://pubmed.ncbi.nlm.nih.gov/23661576
Autor:
Umberto Malapelle, Marcello Tiseo, Ana Vivancos, Joshua Kapp, M. Josè Serrano, Markus Tiemann
Publikováno v:
Journal of Molecular Pathology, Vol 2, Iss 3, Pp 255-273 (2021)
The development of targeted therapies has improved survival rates for patients with advanced non-small cell lung cancer (NSCLC). However, tissue biopsy is unfeasible or inadequate in many patients, limiting biomarker testing and access to targeted th
Externí odkaz:
https://doaj.org/article/42ff0590d4bf497487c19e5b589dbfa0
Autor:
José A. Lorente, Jose Manuel Ordonez, Jose L. Garcia-Puche, Juan José Diaz-Monchon, Francisco G. Ortega, Diego Perez, M. Jose Serrano
Publikováno v:
Journal of Clinical Oncology. 33:e22025-e22025
e22025 Background: To develop clinical applications of Circulating Tumor Cells (CTC), their phenotypic and genetic characterization is required. Here, we present the first protocol to detect miRNAs...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::decb07b2616faf9226f4934a93220036
https://doi.org/10.1200/jco.2015.33.15_suppl.e22025
https://doi.org/10.1200/jco.2015.33.15_suppl.e22025